Drugs / meprogesterone acetate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06914297 | Apr 2025 → Oct 2027 expected | endometrial cancer | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | meprogesterone acetate | “meprogesterone acetate (MA, 160 mg qdpo)” NCT06914297 ↗ |
| Route | Oral | “meprogesterone acetate (MA, 160 mg qdpo)” NCT06914297 ↗ |